Rinat F. Salikov
Russian Academy of Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rinat F. Salikov.
Bioorganic & Medicinal Chemistry Letters | 2015
Rinat F. Salikov; Aleksandr Yu. Belyy; Nailya S. Khusnutdinova; Yulia V. Vakhitova; Yury V. Tomilov
The cyclopropyliminium and subsequent Grandberg rearrangements of cyclopropylketone hydrozones lead to the formation of tryptamines, which were additionally substituted at either the aromatic ring atoms or the amino group. The products were tested for their cytotoxic properties against HepG2, Jurkat and HEK293 cell lines using MTT assay. The highest activity as well as the highest selectivity was found amongst the compounds derived with one benzyl substituent at the amino group. The flow cytometry technique revealed cell-type specificity in terms of the mechanism of viability inhibition. Thus, the compounds were found to induce mainly apoptosis in HEK293 and HepG2 cells, while Jurkat cells displayed late apoptotic and necrotic responses. The apoptosis pathway is most likely to include mitochondrial damage.
Journal of Organic Chemistry | 2017
Rinat F. Salikov; Konstantin P. Trainov; Anastasia A. Levina; Irina K. Belousova; Michael G. Medvedev; Yury V. Tomilov
The rearrangement of cyclopropylketone arylhydrazones generated in situ from arylhydrazine hydrochlorides and ketones leads to formation of tryptamine derivatives. The use of (2-arylcyclopropyl)ethanones in the reactions with model 4-bromophenylhydrazine hydrochloride gives branched tryptamines with aryl groups in the α-position to the amino group, while (2-methylcyclopropyl)ethanone gives a mixture of α- and β-substituted products in a ratio of 1:3. The method was found effective in the synthesis of enantiomerically pure tryptamine. Thus, (R,R)-(2-phenylcyclopropyl)ethanone gives the (S)-α-phenyltryptamine derivative with an enantiomeric excess over 99%.
European Journal of Medicinal Chemistry | 2018
Rinat F. Salikov; Konstantin P. Trainov; Irina K. Belousova; Aleksandr Yu. Belyy; Ulyana Sh. Fatkullina; Regina V. Mulyukova; L. F. Zainullina; Yulia V. Vakhitova; Yury V. Tomilov
The influence of a series of tryptamine derivatives on the viability of normal (HEK293) and tumor (HepG2, Jurkat and SH-SY5Y) cells has been evaluated. All tryptamines tested were three different substitution types: C- and N-branching, and indole benzylation. All the derivations enhance the activity of compounds separately, although the effects of different substitutions were not additive. Thus, combinations of C- and N-branchings as well as C-branching and indole benzylation gave little or no increase in activity.
Tetrahedron | 2008
Yury V. Tomilov; Dmitry N. Platonov; Rinat F. Salikov; Galina P. Okonnishnikova
Tetrahedron Letters | 2010
Yury V. Tomilov; Dmitry N. Platonov; Aleksandr E. Frumkin; Dmitry L. Lipilin; Rinat F. Salikov
Tetrahedron Letters | 2014
Rinat F. Salikov; Aleksandr Yu. Belyy; Yury V. Tomilov
Tetrahedron | 2013
Rinat F. Salikov; Dmitry N. Platonov; Aleksandr E. Frumkin; Dmitry L. Lipilin; Yury V. Tomilov
Mendeleev Communications | 2013
Yury V. Tomilov; Rinat F. Salikov; Dmitry N. Platonov; Dmitry L. Lipilin; Aleksandr E. Frumkin
Synlett | 2018
Alexander Yu. Belyy; Dmitry N. Platonov; Rinat F. Salikov; Anastasiya A. Levina; Yury V. Tomilov
Tetrahedron Letters | 2016
Dmitry N. Platonov; Galina P. Okonnishnikova; Rinat F. Salikov; Yury V. Tomilov